Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 25.59M | $ 35.74M | $ 34.65M | $ 36.09M | $ 35.22M |
Total Assets | $ 155.26M | $ 165.19M | $ 157.00M | $ 157.59M | $ 153.52M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 29.89M | $ 33.70M | $ 28.16M | $ 28.13M | $ 27.36M |
Stockholders Equity | $ 125.37M | $ 131.50M | $ 128.84M | $ 129.46M | $ 126.17M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |